Stock Scorecard
Stock Summary for Veru Inc (VERU) - $2.48 as of 9/9/2026 8:47:17 PM EST
Total Score
11 out of 30
Safety Score
21 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for VERU
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VERU
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VERU
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for VERU
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for VERU (21 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for VERU
Financial Details for VERU
Company Overview |
|
|---|---|
| Ticker | VERU |
| Company Name | Veru Inc |
| Country | USA |
| Description | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 2.48 |
| Price 4 Years Ago | 52.80 |
| Last Day Price Updated | 9/9/2026 8:47:17 PM EST |
| Last Day Volume | 264,785 |
| Average Daily Volume | 237,459 |
| 52-Week High | 4.59 |
| 52-Week Low | 2.05 |
| Last Price to 52 Week Low | 20.98% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 37.78 |
| Sector PE | 48.42 |
| 5-Year Average PE | -6.22 |
| Free Cash Flow Ratio | 1.77 |
| Industry Free Cash Flow Ratio | 37.59 |
| Sector Free Cash Flow Ratio | 38.47 |
| Current Ratio Most Recent Quarter | 4.42 |
| Total Cash Per Share | 1.40 |
| Book Value Per Share Most Recent Quarter | 1.66 |
| Price to Book Ratio | 1.59 |
| Industry Price to Book Ratio | 3.72 |
| Sector Price to Book Ratio | 21.42 |
| Price to Sales Ratio Twelve Trailing Months | 3.11 |
| Industry Price to Sales Ratio Twelve Trailing Months | 10.75 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.15 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 17,050,300 |
| Market Capitalization | 42,284,744 |
| Institutional Ownership | 19.70% |
Dividends |
|
| Ex-Dividend Date | 4/28/2014 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0700 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -48.15% |
| 3-Year Dividend Growth Rate Percentage | -21.98% |
| 5-Year Dividend Growth Rate Percentage | -8.53% |
| All-Time Dividend Growth Rate Percentage | -8.53% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 39.88% |
| Reported EPS 12 Trailing Months | -0.61 |
| Reported EPS Past Year | -0.69 |
| Reported EPS Prior Year | -1.75 |
| Net Income Twelve Trailing Months | -13,608,554 |
| Net Income Past Year | -22,726,279 |
| Net Income Prior Year | -37,801,426 |
| Quarterly Revenue Growth YOY | 18.30% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 23,880,142 |
| Total Cash Past Year | 15,794,562 |
| Total Cash Prior Year | 24,916,285 |
| Net Cash Position Most Recent Quarter | 15,029,350 |
| Net Cash Position Past Year | 6,943,770 |
| Long Term Debt Past Year | 8,850,792 |
| Long Term Debt Prior Year | 8,850,792 |
| Total Debt Most Recent Quarter | 8,850,792 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.76 |
| Total Stockholder Equity Past Year | 18,332,670 |
| Total Stockholder Equity Prior Year | 32,316,712 |
| Total Stockholder Equity Most Recent Quarter | 28,376,240 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -26,043,005 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.53 |
| Free Cash Flow Past Year | -30,044,171 |
| Free Cash Flow Prior Year | -21,840,655 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.05 |
| MACD Signal | 0.03 |
| 20-Day Bollinger Lower Band | 1.88 |
| 20-Day Bollinger Middle Band | 2.58 |
| 20-Day Bollinger Upper Band | 3.28 |
| Beta | -1.16 |
| RSI | 61.42 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 5.76 |
| 200-Day SMA | 11.79 |
System |
|
| Modified | 9/8/2026 10:28:15 AM EST |